Journey Clinical is on a mission to transform the growing mental health crisis by accelerating the adoption of frontier treatments that lead to lasting improvements in clinical outcomes. We have built a turnkey healthtech platform to safely and effectively expand access to a powerful modality known as Psychedelic-Assisted Psychotherapy, starting with Ketamine-Assisted Psychotherapy (KAP). In our patient-centered collaborative care model, licensed psychotherapists in the network take on the psychotherapy, while Journey Clinical's in-house medical team takes on patient eligibility, treatment plan and outcome monitoring. Our platform gives psychotherapists passionate about PAP the infrastructure and support required to become empowered KAP providers, while enabling higher standards of patient care and enhanced clinical outcomes.

We have recently closed a successful Series A round led by Union Square Ventures, and are backed by a number of top-tier investors including AlleyCorp, Fifty Years, Able Partners, Gaingels, Palo Santo, PsyMed Ventures, Coalition Operators, Christina Sass co-founder of Andela, Edvard Engesæth, MD co-founder of Nurx and, Hans Gangeskar co-founder of Nurx.

We are building an open-minded and inclusive workplace where you will have the opportunity to grow and collaborate with a diverse team of high performing individuals. Our team combines extensive experience in business and healthcare.

We are mission driven and strive to make the workplace stimulating, ethical, rewarding, and fun. Together, we will be working at the cutting edge of a groundbreaking field that is reshaping mental health and we will make a direct impact on people’s lives.

Responsibilities:

- Conduct patient intake and follow up consultations to evaluate ketamine-assisted psychotherapy (KAP) eligibility, prescribe, and monitor patient outcomes via telemedicine

- Suggest treatment plan changes based on patient response to medication and treatment outcomes

- Engage in collaborative care with Journey Clinical member psychotherapists

- Work with Journey Clinical care coordinator to streamline your workflow

- Continuously and promptly give honest feedback on the Journey Clinical care management system to improve our services

- Report directly to the Lead Clinician and collaborate with the leadership team and the co-founders

Profile:

- Licensed to practice in Connecticut

- Preferred: 1 year psych experience as a PMHNP

- Minimum 1 year psych related experience + post boards

- DEA registration

- Comfortable prescribing controlled substances when medically appropriate

- Comfortable prescribing for anxiety and depression

- Ability to quickly synthesize medical and psychiatric information about the patient to formulate effective and evidence-based clinical recommendations

- Patient-first mindset, deep work ethic and dedication to the highest level of patient care

- Willing to use a few simple tools to make your life easier (Slack, G Suite, Zoom, etc.)

- Comfortable working remotely in a Telehealth fast-paced startup environment

- Interest for the field of psychedelic-assisted psychotherapy to transform mental health

What we offer:

- Competitive hourly rate

- Flexible working hours

- Ketamine-assisted psychotherapy (KAP) prescriber training and mentorship given by leading industry experts

- Work with a team of industry leading experts, who are highly collaborative, disciplined, and who have fun working together

- The opportunity to change the way we approach mental health by advancing the mainstream adoption of psychedelic assisted psychotherapy and make a positive impact on the lives of 100M+ people who are suffering from depression and anxiety in the US today!

If you feel discouraged by the job description because your skills don’t exactly match please apply anyway. We likely missed something and are open to expanding our understanding of the role. We are an Equal Opportunity Employer and consider applicants for employment without regard to race, color, religion, sex, orientation, national origin, age, disability, genetics or any other basis forbidden under federal, state, or local law.

About the company

Journey Clinical offers Ketamine-Assisted Psychotherapy (KAP) for depression, anxiety, and PTSD. It acts as a one-stop treatment partner where a medical consultation leads to ketamine prescription, administration, and accompanying psychotherapy in a coordinated care plan. The approach blends ketamine's effects with structured psychotherapy to tackle symptoms from multiple angles under medical oversight. The company stands out with a patient-centered, collaborative care model and a team of MDs, PhDs, and licensed clinicians delivering personalized, accessible therapy.

Company Size

51-200

Company Stage

Series A

Total Funding

$11.5M

Headquarters

New York City, null

Founded

2020

Get referred to Journey Clinical

See people who can refer or advise you

Simplify's Take

What believers are saying

DEA telemedicine flexibilities stay open through December 31, 2026, supporting remote ketamine prescribing.
Journey Clinical says major insurers cover KAP, and patients receive reimbursement in 30 states.
The 2026 White House executive order boosts psychedelic medicine attention and future access pathways.

What critics are saying

DEA telemedicine relief expires December 31, 2026; tighter rules would break its remote workflow.
Georgia's 2026 ketamine-clinic law signals state licensing, ownership, and staffing scrutiny spreading nationwide.
FDA ketamine safety warnings and compounding crackdowns threaten prescriber confidence, referrals, and Journey Clinical's existential market.

What makes Journey Clinical unique

Journey Clinical runs therapist-led KAP with in-network prescribers across 30 states.
It claims the largest U.S. psychedelic-assisted psychotherapy provider network, anchored by thousands of therapists.
Its model keeps therapists independent while Journey Clinical handles medical oversight and prescribing.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours
Remote Work Options
Training Programs
Hybrid Work Options

Growth & Insights and Company News

Headcount

6 month growth

1 year growth

-1%

2 year growth

The Juniper Center

Aug 4th, 2025

What is Ketamine-Assisted Psychotherapy?

For those curious to learn more, The Juniper Center has partnered with Journey Clinical - a platform that connects therapists with licensed prescribers and offers research and resources on KAP for both clients and providers.

Gateway to Solutions

Jun 21st, 2024

Ketamine-Assisted Psychotherapy (KAP) at Gateway to Solutions

Gateway to Solutions, a trusted provider of ketamine-assisted psychotherapy for eight years, has recently partnered with Journey Clinical for a seamless and collaborative KAP experience.

Crain Communications

May 1st, 2024

Compass Pathways, Journey Clinical to develop psilocybin treatment delivery model

Compass Pathways plc (Nasdaq: CMPS) entered into a research collaboration agreement this week with Journey Clinical, a U.S.-based psychedelic-assisted psychotherapy platform.

Journey Clinical

Dec 19th, 2023

Building a Network of KAP Providers with IPI

This October, Journey Clinical launched a partnership with the Integrative Psychiatry Institute (IPI) to support their students and graduates in becoming successful Ketamine-Assisted Psychotherapy providers.

Journey Clinical

Apr 10th, 2023

SXSW Panel: The Business of Psychedelics featuring Myriam Barthes

Journey Clinical partnered up with Fluence to offer some training and then they also needed professional resource in order to grow their practice.